Zydus's Virafin Gets DGCI Approval To Treat Mild COVID-19 Infections
Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases
Vaccine maker Zydus Cadila gets emergency use authorisation for 'Virafin'
Virafin, Zydus's New Covid Drug Which Cuts Need For Oxygen & Recovery Time, Gets Emergency Approval
DCGI-Approved Virafin Claims 91% COVID Patients Return Negative In 7 Days
Headlines: DCGI Gives Nod To Zydus To Use Virafin, Hospital Claims 91.15% Success
Zydus Cadila's Coronavirus vaccine Virafin gets emergency use approval
What is Virafin? How does the Zydus Cadila drug work? | Oneindia News
India: New COVID drug gets regulator's nod | Virafin | Zydus Cadila
Zydus Cadila’s Virafin Receives Emergency Use Approval For #COVID-19 Treatment | OTV News
Zydus Gets DCGI Nod for Emergency Use of Antiviral Drug -Virafin || Hybiz tv
DCGI Approves Virafin Antiviral Drug which Reduces Viral Load and Need of Oxygen | Ntv
Virafin - Treatment of Moderate COVID-19 Infections | आपातकालीन उपयोग के लिए (DGCI) | Dr. Geetendra
#VIRAFIN by ZYDUS Cadila: New covid19 drug:: FACTS, DOSE, MECHANISM, and FUTURE ASPECTS
మార్కెట్లోకి మరో వ్యాక్సిన్|Zydus' Antiviral Virafin Receives Emergency Authorisation for COVID-19
DCGI Approves Zydus Cadila's Anti-Viral 'Virafin' To Treat Moderate COVID-19 Infection
DGCI Green Signal To Zydus Cadila's VIRAFIN For Emergency Use | Sakshi TV
DGCI Approves Emergency Use Of Zydus Cadila's Virafin For Moderate COVID-19 Infection
DCGI Approves Zydus Cadila’s ‘Virafin’ To Treat #COVID19 Patients
TREATMENT of COVID 19 , VACCINE IN FUTURE , Zydus Cadila : VIRAFIN, COVAVAX , SPUTNIK V ,Updates
